GLAUKOS Corp·4

May 4, 6:40 PM ET

Thurman Alex R. 4

4 · GLAUKOS Corp · Filed May 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Glaukos (GKOS) CFO Alex R. Thurman Exercises Options, Sells 10,000 Shares

What Happened Alex R. Thurman, Chief Financial Officer of Glaukos Corp (GKOS), exercised options to acquire 10,000 shares at an exercise price of $38.68 per share (cost $386,800) on April 30, 2026, and sold 10,000 shares in an open-market transaction at $140.00 per share for proceeds of $1,400,000. The filing also shows a derivative disposition of 10,000 shares at $38.68 (likely part of the exercise/settlement process). The transactions were effected under a pre-established Rule 10b5-1 trading plan.

Key Details

  • Transaction date: April 30, 2026; Form 4 filed May 4, 2026 (appears timely).
  • Option exercise: 10,000 shares at $38.68 each = $386,800 (acquired).
  • Open-market sale: 10,000 shares at $140.00 each = $1,400,000 (disposed).
  • Derivative disposition: 10,000 shares at $38.68 each = $386,800 (listed as disposed).
  • Sales and option exercises were executed pursuant to a Rule 10b5-1 plan adopted December 15, 2025 (footnotes F2, F3).
  • Filing footnote indicates 5,230 restricted stock units (RSUs) remain unvested/not delivered (F1).
  • Option vesting schedule noted in filing: four-year vesting with 25% after one year, then monthly over three years (F4).
  • Shares owned following the transactions: not specified in the provided filing.

Context This appears to be a cashless-style exercise followed by an immediate sale: the CFO exercised options and sold shares the same day under a 10b5-1 plan, a common way for insiders to convert option value to cash while following pre-set trading rules. The use of a 10b5-1 plan means trades were pre-authorized (adopted Dec 15, 2025). These filings are factual records of transactions and do not, by themselves, indicate the insider’s view of the company’s outlook.

Insider Transaction Report

Form 4
Period: 2026-04-30
Thurman Alex R.
SVP & CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-04-30$38.68/sh+10,000$386,80053,681 total
  • Sale

    Common Stock

    [F2][F1]
    2026-04-30$140.00/sh10,000$1,400,00043,681 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3][F4]
    2026-04-30$38.68/sh10,000$386,80030,000 total
    Exercise: $38.68Exp: 2026-10-06Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
  • [F3]The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
  • [F4]These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Signature
Diana Scherer, Attorney-in-Fact|2026-05-04

Documents

1 file
  • 4
    form4-05042026_100528.xmlPrimary